Publications 2024

Frøland SS (2024)
[Not Available]
Tidsskr Nor Laegeforen, 144 (12)
DOI 10.4045/tidsskr.24.0450, PubMed 39404248

Publications 2021

Jonsson R, Ljunggren HG, Wigzell H, Froland SS, Meri S, Dembic Z, Orn A (2021)
Jacob B. Natvig (1934-2021), one of the founders of Scandinavian Journal of Immunology OBITURY
Scand. J. Immunol., 94 (1), e13053
DOI 10.1111/sji.13053

Publications 2019

Frøland SS (2019)
[Fecal transplantation and the microbiome]
Tidsskr Nor Laegeforen, 139 (11)
DOI 10.4045/tidsskr.19.0445, PubMed 31429237

Publications 2018

Siljan WW, Holter JC, Nymo SH, Husebye E, Ueland T, Skattum L, Bosnes V, Garred P, Frøland SS, Mollnes TE, Aukrust P, Heggelund L (2018)
Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia
Open Forum Infect Dis, 5 (2), ofy002
DOI 10.1093/ofid/ofy002, PubMed 29410975

Publications 2016

Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L (2016)
Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
PLoS One, 11 (2), e0148741
DOI 10.1371/journal.pone.0148741, PubMed 26849359

Holter JC, Ueland T, Norseth J, Brunborg C, Frøland SS, Husebye E, Aukrust P, Heggelund L (2016)
Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort
PLoS One, 11 (7), e0158536
DOI 10.1371/journal.pone.0158536, PubMed 27367810

Publications 2015

Heggelund L, Gaustad P, Håvelsrud OE, Blom J, Borgen L, Sundset A, Sørum H, Frøland SS (2015)
Corynebacterium pseudotuberculosis Pneumonia in a Veterinary Student Infected During Laboratory Work
Open Forum Infect Dis, 2 (2), ofv053
DOI 10.1093/ofid/ofv053, PubMed 26380345

Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L (2015)
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
BMC Infect Dis, 15, 64
DOI 10.1186/s12879-015-0803-5, PubMed 25887603

Publications 2014

Frøland SS (2014)
[When force is necessary]
Tidsskr Nor Laegeforen, 134 (14), 1342
DOI 10.4045/tidsskr.14.0795, PubMed 25096418

Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
Clin Exp Immunol, 175 (3), 439-48
DOI 10.1111/cei.12239, PubMed 24237110

Publications 2013

Gregersen S, Holm AM, Fevang B, Ueland T, Sikkeland LI, Aaløkken TM, Mynarek G, Kongerud J, Aukrust P, Johansen B, Frøland SS (2013)
Lung disease, T-cells and inflammation in common variable immunodeficiency disorders
Scand J Clin Lab Invest, 73 (6), 514-22
DOI 10.3109/00365513.2013.819523, PubMed 23957371

Svalheim S, Mushtaq U, Mochol M, Luef G, Rauchenzauner M, Frøland SS, Taubøll E (2013)
Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine
Acta Neurol Scand Suppl (196), 11-5
DOI 10.1111/ane.12044, PubMed 23190286

Publications 2012

Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592

Harboe E, Damås JK, Omdal R, Frøland SS, Sjursen H (2012)
[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]
Tidsskr Nor Laegeforen, 132 (16), 1867-71
DOI 10.4045/tidsskr.12.0180, PubMed 22986971

Rødland EK, Ueland T, Bjørnsen S, Sagen EL, Dahl CP, Naalsund A, Mollnes TE, Brosstad FR, Müller F, Aukrust P, Frøland SS (2012)
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
BMC Infect Dis, 12, 144
DOI 10.1186/1471-2334-12-144, PubMed 22731696

Publications 2011

Landrø L, Ueland T, Otterdal K, Frøland SS, Aukrust P (2011)
Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy
J Thromb Haemost, 9 (5), 1075-7
DOI 10.1111/j.1538-7836.2011.04242.x, PubMed 21324059

Publications 2010

Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
J Acquir Immune Defic Syndr, 53 (3), 419-20
DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590

Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
Ann Allergy Asthma Immunol, 104 (6), 503-10
DOI 10.1016/j.anai.2010.04.015, PubMed 20568383

Rødland EK, Ager-Wick E, Halvorsen B, Müller F, Frøland SS (2010)
Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro
Med Mycol, 49 (4), 375-9
DOI 10.3109/13693786.2010.531772, PubMed 21067314

Publications 2009

Capra JD, Frøland SS, Harboe M, Jonsson R, Ljunggren HG, Wigzell H (2009)
Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75
Scand J Immunol, 70 (6), 503-4
DOI 10.1111/j.1365-3083.2009.02343.x, PubMed 19906190

Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
AIDS, 23 (1), 135-8
DOI 10.1097/QAD.0b013e32831cf595, PubMed 19050397

Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
Clin Exp Immunol, 157 (3), 400-7
DOI 10.1111/j.1365-2249.2009.03976.x, PubMed 19664149

Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Clin Immunol, 131 (3), 438-46
DOI 10.1016/j.clim.2009.01.007, PubMed 19232508

Fevang B, Yndestad A, Damås JK, Halvorsen B, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation
Clin Exp Immunol, 158 (2), 237-45
DOI 10.1111/j.1365-2249.2009.04013.x, PubMed 19747210

Gregersen S, Aaløkken TM, Mynarek G, Kongerud J, Aukrust P, Frøland SS, Johansen B (2009)
High resolution computed tomography and pulmonary function in common variable immunodeficiency
Respir Med, 103 (6), 873-80
DOI 10.1016/j.rmed.2008.12.015, PubMed 19181508

Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P (2009)
CXCL16 in HIV infection - a link between inflammation and viral replication
Eur J Clin Invest, 39 (11), 1017-24
DOI 10.1111/j.1365-2362.2009.02207.x, PubMed 19674076

Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2009)
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
Infect Immun, 78 (3), 1269-75
DOI 10.1128/IAI.01091-09, PubMed 20008537

Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
J Immunol, 182 (1), 588-95
DOI 10.4049/jimmunol.182.1.588, PubMed 19109192

Sandberg WJ, Otterdal K, Gullestad L, Halvorsen B, Ragnarsson A, Frøland SS, Damås JK, Oie E, Aukrust P, Hansson GK, Yndestad A (2009)
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Thromb Haemost, 102 (4), 704-10
DOI 10.1160/TH08-10-0665, PubMed 19806256

Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur Heart J, 30 (10), 1229-36
DOI 10.1093/eurheartj/ehp088, PubMed 19329498

Publications 2008

Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P (2008)
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
Arterioscler Thromb Vasc Biol, 28 (5), 1005-11
DOI 10.1161/ATVBAHA.108.162305, PubMed 18276907

Bryn T, Mahic M, Aandahl EM, Frøland SS, Aukrust P, Taskén K (2008)
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients
AIDS Res Hum Retroviruses, 24 (7), 1013-5
DOI 10.1089/aid.2008.0071, PubMed 18593346

Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
Eur J Heart Fail, 10 (4), 352-9
DOI 10.1016/j.ejheart.2008.02.010, PubMed 18353719

Damås JK, Davì G, Jensenius M, Santilli F, Otterdal K, Ueland T, Flo TH, Lien E, Espevik T, Frøland SS, Vitale G, Raoult D, Aukrust P (2008)
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
J Infect, 58 (1), 68-75
DOI 10.1016/j.jinf.2008.11.008, PubMed 19091423

Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2008)
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
Clin Immunol, 130 (2), 151-61
DOI 10.1016/j.clim.2008.09.002, PubMed 18938112

Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
Clin Exp Immunol, 152 (1), 57-63
DOI 10.1111/j.1365-2249.2008.03592.x, PubMed 18241231

Rødland EK, Mattingsdal M, Olstad OK, Ovstebø R, Kierulf P, Muller F, Frøland SS (2008)
Expression of genes in normal human monocytes in response to Aspergillus fumigatus
Med Mycol, 46 (4), 327-36
DOI 10.1080/13693780701874507, PubMed 18415839

Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Frøland SS, Olofsson PS, Damås JK, Gullestad L, Hansson GK, Oie E, Aukrust P (2008)
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
Circ Res, 104 (1), 60-8
DOI 10.1161/CIRCRESAHA.108.188078, PubMed 19023130

Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
Cardiovasc Res, 79 (1), 195-203
DOI 10.1093/cvr/cvn071, PubMed 18339644

Publications 2007

Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS (2007)
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
Rheumatology (Oxford), 46 (9), 1422-7
DOI 10.1093/rheumatology/kem168, PubMed 17616549

Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-80
DOI 10.1161/CIRCULATIONAHA.106.665893, PubMed 17283255

Fevang B, Yndestad A, Sandberg WJ, Holm AM, Müller F, Aukrust P, Frøland SS (2007)
Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo
Clin Exp Immunol, 147 (3), 521-5
DOI 10.1111/j.1365-2249.2006.03314.x, PubMed 17302902

Publications 2006

Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L (2006)
The role of intravenous immunoglobulin in the treatment of chronic heart failure
Int J Cardiol, 112 (1), 40-5
DOI 10.1016/j.ijcard.2006.05.015, PubMed 16893578

Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
J Immunol, 177 (4), 2699-706
DOI 10.4049/jimmunol.177.4.2699, PubMed 16888032

Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2006)
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
Arterioscler Thromb Vasc Biol, 27 (3), 614-20
DOI 10.1161/01.ATV.0000255581.38523.7c, PubMed 17170367

Frøland SS (2006)
[Common variable immunodeficiency]
Tidsskr Nor Laegeforen, 126 (5), 615
PubMed 16550642

Frøland SS (2006)
[25 years of the AIDS epidemic]
Tidsskr Nor Laegeforen, 126 (23), 3140-4
PubMed 17160123

Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
Clin Exp Immunol, 144 (3), 418-24
DOI 10.1111/j.1365-2249.2006.03086.x, PubMed 16734610

Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964

Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
Arterioscler Thromb Vasc Biol, 26 (4), 857-63
DOI 10.1161/01.ATV.0000204334.48195.6a, PubMed 16424351

Smith C, Damås JK, Otterdal K, Øie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Frøland SS, Hansson GK, Aukrust P (2006)
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
J Am Coll Cardiol, 48 (8), 1591-9
DOI 10.1016/j.jacc.2006.06.060, PubMed 17045893

Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
J Card Fail, 12 (8), 659-63
DOI 10.1016/j.cardfail.2006.07.002, PubMed 17045187

Ueland T, Gullestad L, Simonsen S, Endresen K, Scott H, Frøland SS, Geiran O, Fiane AE, Aukrust P (2006)
Decreased endomyocardial RANKL expression in transplant coronary artery disease
Transplantation, 81 (10), 1467-70
DOI 10.1097/01.tp.0000209413.45179.f6, PubMed 16732187

Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
J Thromb Haemost, 4 (10), 2140-7
DOI 10.1111/j.1538-7836.2006.02131.x, PubMed 16856976

Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E (2006)
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Eur J Heart Fail, 8 (8), 790-6
DOI 10.1016/j.ejheart.2006.02.007, PubMed 16549389

Publications 2005

Aukrust P, Luna L, Ueland T, Johansen RF, Müller F, Frøland SS, Seeberg EC, Bjørås M (2005)
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
Blood, 105 (12), 4730-5
DOI 10.1182/blood-2004-11-4272, PubMed 15705786

Fevang B, Mollnes TE, Holm AM, Ueland T, Heggelund L, Damås JK, Aukrust P, Frøland SS (2005)
Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
Clin Exp Immunol, 142 (3), 576-84
DOI 10.1111/j.1365-2249.2005.02951.x, PubMed 16297171

Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
Eur Heart J, 26 (16), 1660-5
DOI 10.1093/eurheartj/ehi198, PubMed 15821010

Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
Circulation, 112 (22), 3408-14
DOI 10.1161/CIRCULATIONAHA.105.564971, PubMed 16301340

Heggelund L, Mollnes TE, Espevik T, Müller F, Kristiansen KI, Aukrust P, Frøland SS (2005)
Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection
Eur J Clin Invest, 35 (12), 765-70
DOI 10.1111/j.1365-2362.2005.01579.x, PubMed 16313253

Holven KB, Damås JK, Yndestad A, Waehre T, Ueland T, Halvorsen B, Heggelund L, Sandberg WJ, Semb AG, Frøland SS, Ose L, Nenseter MS, Aukrust P (2005)
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
Arterioscler Thromb Vasc Biol, 26 (1), 200-5
DOI 10.1161/01.ATV.0000193619.67288.ed, PubMed 16254204

Scholz H, Sandberg W, Damås JK, Smith C, Andreassen AK, Gullestad L, Frøland SS, Yndestad A, Aukrust P, Halvorsen B (2005)
Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis
Circulation, 112 (14), 2121-9
DOI 10.1161/CIRCULATIONAHA.105.544676, PubMed 16186421

Sigstad HM, Stray-Pedersen A, Frøland SS (2005)
Coping, quality of life, and hope in adults with primary antibody deficiencies
Health Qual Life Outcomes, 3, 31
DOI 10.1186/1477-7525-3-31, PubMed 15871746

Stavem K, Frøland SS, Hellum KB (2005)
Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS
Qual Life Res, 14 (4), 971-80
DOI 10.1007/s11136-004-3211-7, PubMed 16041894

Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Frøland SS (2005)
Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro
Clin Exp Immunol, 140 (2), 376-83
DOI 10.1111/j.1365-2249.2005.02770.x, PubMed 15807865

Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK (2005)
Soluble CD40 ligand in acute and chronic heart failure
Eur Heart J, 26 (11), 1101-7
DOI 10.1093/eurheartj/ehi132, PubMed 15716285

Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P (2005)
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
J Am Coll Cardiol, 46 (11), 2018-21
DOI 10.1016/j.jacc.2005.08.039, PubMed 16325035

Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005)
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
Circulation, 111 (19), 2461-8
DOI 10.1161/01.CIR.0000165119.62099.14, PubMed 15883214

Publications 2004

Bjerkeli V, Halvorsen B, Damås JK, Nordøy I, Yndestad A, Aukrust P, Frøland SS (2004)
Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
Ann Rheum Dis, 63 (12), 1659-63
DOI 10.1136/ard.2003.017954, PubMed 15547092

Damås JK, Otterdal K, Yndestad A, Aass H, Solum NO, Frøland SS, Simonsen S, Aukrust P, Andreassen AK (2004)
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells
Circulation, 110 (8), 999-1005
DOI 10.1161/01.CIR.0000139859.68513.FC, PubMed 15302794

Fredriksen J, Ueland T, Dyrøy E, Halvorsen B, Melby K, Melbye L, Skalhegg BS, Bohov P, Skorve J, Berge RK, Aukrust P, Frøland SS (2004)
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
Eur J Clin Invest, 34 (10), 709-15
DOI 10.1111/j.1365-2362.2004.01410.x, PubMed 15473896

Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P (2004)
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
J Lipid Res, 46 (2), 211-9
DOI 10.1194/jlr.M400324-JLR200, PubMed 15547296

Heggelund L, Damås JK, Yndestad A, Holm AM, Mūller F, Lien E, Espevik T, Aukrust P, Frøland SS (2004)
Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences
Clin Exp Immunol, 138 (1), 116-21
DOI 10.1111/j.1365-2249.2004.02595.x, PubMed 15373913

Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS (2004)
Soluble toll-like receptor 2 in HIV infection: association with disease progression
AIDS, 18 (18), 2437-9
PubMed 15622324

Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
Clin Infect Dis, 39 (2), 264-9
DOI 10.1086/421780, PubMed 15307037

Holm AM, Aukrust P, Damås JK, Müller F, Halvorsen B, Frøland SS (2004)
Abnormal interleukin-7 function in common variable immunodeficiency
Blood, 105 (7), 2887-90
DOI 10.1182/blood-2004-06-2423, PubMed 15598813

Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
Clin Exp Immunol, 138 (2), 278-89
DOI 10.1111/j.1365-2249.2004.02630.x, PubMed 15498038

Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Frøland SS, Aukrust P, Taskén K (2004)
Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP
AIDS, 18 (2), 171-9
DOI 10.1097/00002030-200401230-00005, PubMed 15075533

Johansson CC, Bryn T, Aandahl EM, Areklett MA, Aukrust P, Taskén K, Frøland SS (2004)
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
AIDS, 18 (6), 951-2
DOI 10.1097/00002030-200404090-00015, PubMed 15060445

Laake JH, Bergmann JB, Riddervold F, Bjørneklett A, Aukrust P, Frøland SS (2004)
[Should patients with severe sepsis be treated with activated protein C?]
Tidsskr Nor Laegeforen, 124 (6), 782-4
PubMed 15039808

Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P (2004)
Potential anti-inflammatory role of activin A in acute coronary syndromes
J Am Coll Cardiol, 44 (2), 369-75
DOI 10.1016/j.jacc.2004.03.069, PubMed 15261933

Waehre T, Damås JK, Yndestad A, Taskén K, Pedersen TM, Smith C, Halvorsen B, Frøland SS, Solum NO, Aukrust P (2004)
Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2
Thromb Haemost, 92 (6), 1358-67
DOI 10.1160/TH04-03-0146, PubMed 15583745

Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK (2004)
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
Circulation, 109 (16), 1966-72
DOI 10.1161/01.CIR.0000125700.33637.B1, PubMed 15051633

Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P (2004)
Elevated levels of activin A in heart failure: potential role in myocardial remodeling
Circulation, 109 (11), 1379-85
DOI 10.1161/01.CIR.0000120704.97934.41, PubMed 14993131

Publications 2003

Aukrust P, Müller F, Svardal AM, Ueland T, Berge RK, Frøland SS (2003)
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
J Infect Dis, 188 (2), 232-8
DOI 10.1086/376459, PubMed 12854078

Aukrust P, Wergedahl H, Müller F, Ueland T, Dyrøy E, Damås JK, Frøland SS, Berge RK (2003)
Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells
Eur J Clin Invest, 33 (5), 426-33
DOI 10.1046/j.1365-2362.2003.01140.x, PubMed 12713457

Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P (2003)
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets
Circulation, 107 (21), 2670-6
DOI 10.1161/01.CIR.0000070542.18001.87, PubMed 12742982

Frøland SS (2003)
[20 years with AIDS in Norway]
Tidsskr Nor Laegeforen, 123 (22), 3178
PubMed 14714001

Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Frøland SS (2003)
Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy
J Acquir Immune Defic Syndr, 32 (4), 354-61
DOI 10.1097/00126334-200304010-00002, PubMed 12640191

Holm AM, Aukrust P, Aandahl EM, Müller F, Taskén K, Frøland SS (2003)
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I
J Immunol, 170 (11), 5772-7
DOI 10.4049/jimmunol.170.11.5772, PubMed 12759461

Holm T, Damås JK, Holven K, Nordøy I, Brosstad FR, Ueland T, Währe T, Kjekshus J, Frøland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P (2003)
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
J Thromb Haemost, 1 (2), 257-62
DOI 10.1046/j.1538-7836.2003.00065.x, PubMed 12871498

Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
Cytomegalovirus infection induces production of human interleukin-10 in macrophages
Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
DOI 10.1007/s10096-003-1028-x, PubMed 14610657

Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD, Frøland SS, Kastelein JJ, Gullestad L, Pedersen TR, Aukrust P, Stalenhoef AF (2003)
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
J Am Coll Cardiol, 41 (2), 275-9
DOI 10.1016/s0735-1097(02)02718-3, PubMed 12535822

Semb AGP, Wissen S, Ueland T, Smilde T, Wæhre T, Tripp MD, Froland SS, Kastelein JJ, Gullestad L, Pedersen TR, Aukrust P, Stalenhoef AF (2003)
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
In Journal of the American College of Cardiology, Elsevier, New York, 41(2003)2, s.275-9
BIBSYS 041726308

Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås JK, Aukrust P, Frøland SS (2003)
Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients
Clin Exp Immunol, 132 (3), 462-6
DOI 10.1046/j.1365-2249.2003.02179.x, PubMed 12780693

Ueland T, Sikkeland LI, Yndestad A, Eiken HG, Holm T, Guevara C, Haug T, Endresen K, Frøland SS, Gullestad L, Andreassen AK, Geiran O, Simonsen S, Aukrust P (2003)
Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
Am J Cardiol, 92 (6), 715-7
DOI 10.1016/s0002-9149(03)00836-1, PubMed 12972116

Waehre T, Damås JK, Gullestad L, Holm AM, Pedersen TR, Arnesen KE, Torsvik H, Frøland SS, Semb AG, Aukrust P (2003)
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
J Am Coll Cardiol, 41 (9), 1460-7
DOI 10.1016/s0735-1097(03)00263-8, PubMed 12742282

Wæhre T, Damas JK, Gullestad L, Holm AM, Pedersen TR, Arnesen KE, Torsvik H, Froland SS, Semb AGP, Aukrust P (2003)
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
In Journal of the American College of Cardiology, Elsevier, New York, 41(2003)9, s.1460-7
BIBSYS 041728793

Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
Cardiovasc Res, 60 (1), 141-6
DOI 10.1016/s0008-6363(03)00362-6, PubMed 14522416

Publications 2002

Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
Circulation, 106 (1), 36-42
DOI 10.1161/01.cir.0000020001.09990.90, PubMed 12093767

Gullestad L, Semb AG, Holt E, Skårdal R, Ueland T, Yndestad A, Frøland SS, Aukrust P (2002)
Effect of thalidomide in patients with chronic heart failure
Am Heart J, 144 (5), 847-50
DOI 10.1067/mhj.2002.125628, PubMed 12422154

Hammer HB, Aukrust P, Frøland SS (2002)
[Churg-Strauss syndrome after treatment with Singulair (montelukast)]
Tidsskr Nor Laegeforen, 122 (5), 484-6
PubMed 11961976

Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Frøland SS, Gullestad L, Andreassen AK (2002)
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
Transplantation, 74 (10), 1395-400
DOI 10.1097/00007890-200211270-00009, PubMed 12451238

Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J (2002)
Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
Eur J Endocrinol, 146 (3), 389-95
DOI 10.1530/eje.0.1460389, PubMed 11888846

Kvale D, Aaberge IS, Frøland SS (2002)
Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection
Eur J Clin Microbiol Infect Dis, 21 (9), 688-90
DOI 10.1007/s10096-002-0803-4, PubMed 12373505

Liabakk NB, Sundan A, Torp S, Aukrust P, Frøland SS, Espevik T (2002)
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA
J Immunol Methods, 259 (1-2), 119-28
DOI 10.1016/s0022-1759(01)00501-4, PubMed 11730847

Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, Frøland SS (2002)
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
Eur J Clin Invest, 32 (7), 535-40
DOI 10.1046/j.1365-2362.2002.00995.x, PubMed 12153555

Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damås JK, Haug T, Eiken HG, Aukrust P, Frøland SS (2002)
Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients
Clin Exp Immunol, 130 (2), 279-85
DOI 10.1046/j.1365-2249.2002.01980.x, PubMed 12390316

Waehre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P (2002)
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
Eur J Clin Invest, 32 (11), 803-10
DOI 10.1046/j.1365-2362.2002.01069.x, PubMed 12423320

Yndestad A, Damås JK, Geir Eiken H, Holm T, Haug T, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2002)
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
Cardiovasc Res, 54 (1), 175-82
DOI 10.1016/s0008-6363(02)00238-9, PubMed 12062373

Zätterstrøm UK, Hokland BM, Walberg M, Stubhaug A, Aaløkken TM, Frøland SS (2002)
[A throat infection with rapid deterioration]
Tidsskr Nor Laegeforen, 122 (19), 1896-9
PubMed 12362714

Publications 2001

Aukrust P, Berge RK, Ueland T, Aaser E, Damås JK, Wikeby L, Brunsvig A, Müller F, Forfang K, Frøland SS, Gullestad L (2001)
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes
J Am Coll Cardiol, 37 (2), 485-91
DOI 10.1016/s0735-1097(00)01110-4, PubMed 11216967

Aukrust P, Damås JK, Gullestad L, Frøland SS (2001)
Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets
Clin Exp Immunol, 124 (3), 343-5
DOI 10.1046/j.1365-2249.2001.01527.x, PubMed 11472392

Aukrust P, Gullestad L, Lappegård KT, Ueland T, Aass H, Wikeby L, Simonsen S, Frøland SS, Mollnes TE (2001)
Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
Circulation, 104 (13), 1494-500
DOI 10.1161/hc3801.096353, PubMed 11571242

Bjøro K, Petrova EP, Thomas MG, Frøland SS, Williams R, Naoumov NV (2001)
TT virus infection in patients with primary hypogammaglobulinaemia: natural history and relationship to liver disease in the immunocompromised host
Scand J Gastroenterol, 36 (9), 987-93
DOI 10.1080/003655201750305530, PubMed 11521992

Damås JK, Gullestad L, Aass H, Simonsen S, Fjeld JG, Wikeby L, Ueland T, Eiken HG, Frøland SS, Aukrust P (2001)
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin
J Am Coll Cardiol, 38 (1), 187-93
DOI 10.1016/s0735-1097(01)01335-3, PubMed 11451272

Eiken HG, Øie E, Damås JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tønnessen T, Christensen G, Frøland SS, Gullestad L, Attramadal H, Aukrust P (2001)
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
Eur J Clin Invest, 31 (5), 389-97
DOI 10.1046/j.1365-2362.2001.00795.x, PubMed 11380590

Frøland SS (2001)
[Gene therapy in primary immunologic failure]
Tidsskr Nor Laegeforen, 121 (3), 351-4
PubMed 11242882

Frøland SS (2001)
[Gene therapy in HIV infection and other viral infections]
Tidsskr Nor Laegeforen, 121 (4), 473-8
PubMed 11255866

Frøland SS (2001)
[Antiretroviral treatment of HIV infections in 2001]
Tidsskr Nor Laegeforen, 121 (29), 3363
PubMed 11826773

Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Frøland SS, Aukrust P (2001)
Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
Am Heart J, 141 (3), 418-21
DOI 10.1067/mhj.2001.112785, PubMed 11231439

Gullestad L, Aass H, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Wikeby L, Nitter-Hauge S, Fjeld JG, Lien E, Ueland T, Frøland SS, Aukrust P (2001)
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]
Tidsskr Nor Laegeforen, 121 (16), 1902-7
PubMed 11488180

Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P (2001)
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
Circulation, 103 (2), 220-5
DOI 10.1161/01.cir.103.2.220, PubMed 11208680

Helle SI, Ueland T, Ekse D, Frøland SS, Holly JM, Lønning PE, Aukrust P (2001)
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy
J Clin Endocrinol Metab, 86 (1), 227-33
DOI 10.1210/jcem.86.1.7135, PubMed 11232005

Holm T, Andreassen AK, Ueland T, Kjekshus J, Frøland SS, Kjekshus E, Simonsen S, Aukrust P, Gullestad L (2001)
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
Am J Cardiol, 87 (6), 815-8, A9
DOI 10.1016/s0002-9149(00)01516-2, PubMed 11249916

Holm T, Berge RK, Andreassen AK, Ueland T, Kjekshus J, Simonsen S, Frøland S, Gullestad L, Aukrust P (2001)
Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
Transplantation, 72 (4), 706-11
DOI 10.1097/00007890-200108270-00025, PubMed 11544435

Stylianou E, Aukrust P, Müller F, Nordøy I, Frøland SS (2001)
Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression
Cytokine, 14 (1), 56-62
DOI 10.1006/cyto.2000.0850, PubMed 11298493

Ueland T, Bollerslev J, Godang K, Müller F, Frøland SS, Aukrust P (2001)
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis
Eur J Endocrinol, 145 (6), 685-90
DOI 10.1530/eje.0.1450685, PubMed 11720891

Ueland T, Frøland SS, Bollerslev J, Aukrust P (2001)
Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency
Eur J Clin Invest, 31 (1), 72-8
DOI 10.1046/j.1365-2362.2001.00768.x, PubMed 11168441

Publications 2000

Aukrust P, Bjørnsen S, Lunden B, Otterdal K, Ng EC, Ameln W, Ueland T, Müller F, Solum NO, Brosstad F, Frøland SS (2000)
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy
Thromb Haemost, 84 (2), 183-7
PubMed 10959687

Aukrust P, Müller F, Ueland T, Svardal AM, Berge RK, Frøland SS (2000)
Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
Eur J Clin Invest, 30 (3), 252-9
DOI 10.1046/j.1365-2362.2000.00619.x, PubMed 10692003

Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P (2000)
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Cardiovasc Res, 47 (4), 778-87
DOI 10.1016/s0008-6363(00)00142-5, PubMed 10974226

Damås JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Frøland SS, Aukrust P (2000)
CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes
Cardiovasc Res, 45 (2), 428-36
DOI 10.1016/s0008-6363(99)00262-x, PubMed 10728363

Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L (2000)
Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
Clin Transplant, 14 (3), 218-25
DOI 10.1034/j.1399-0012.2000.140307.x, PubMed 10831080

Müller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, Frøland SS (2000)
Virological and immunological effects of antioxidant treatment in patients with HIV infection
Eur J Clin Invest, 30 (10), 905-14
DOI 10.1046/j.1365-2362.2000.00727.x, PubMed 11029606

Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS (2000)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Clin Exp Immunol, 120 (2), 333-7
DOI 10.1046/j.1365-2249.2000.01221.x, PubMed 10792384

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
J Infect Dis, 181 (1), 51-7
DOI 10.1086/315184, PubMed 10608750

Stray-Pedersen A, Abrahamsen TG, Frøland SS (2000)
Primary immunodeficiency diseases in Norway
J Clin Immunol, 20 (6), 477-85
DOI 10.1023/a:1026416017763, PubMed 11202238

Stylianou E, Aukrust P, Bendtzen K, Müller F, Frøland SS (2000)
Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection
Clin Exp Immunol, 119 (3), 479-85
DOI 10.1046/j.1365-2249.2000.01144.x, PubMed 10691920

Stylianou E, Aukrust P, Nordøy I, Müller F, Frøland SS (2000)
Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy
APMIS, 108 (9), 601-7
DOI 10.1034/j.1600-0463.2000.d01-1410.x, PubMed 11110048

Taskén K, Hansson V, Aukrust P, Frøland S, Skålhegg BS, Müller F, Tobin D, Vang T, Torgersen KM, Aandahl EM (2000)
PKAI as a potential target for therapeutic intervention
Drug News Perspect, 13 (1), 12-8
PubMed 12937648

Publications 1999

Aukrust P, Gullestad L, Frøland SS (1999)
Is apoptosis an important pathogenic factor in cardiovascular disease?
Eur J Clin Invest, 29 (5), 369-71
DOI 10.1046/j.1365-2362.1999.00482.x, PubMed 10354192

Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Frøland SS (1999)
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
J Clin Endocrinol Metab, 84 (1), 145-50
DOI 10.1210/jcem.84.1.5417, PubMed 9920075

Aukrust P, Müller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS (1999)
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure
J Infect Dis, 179 (1), 74-82
DOI 10.1086/314572, PubMed 9841825

Aukrust P, Müller F, Svenson M, Nordøy I, Bendtzen K, Frøland SS (1999)
Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system
Clin Exp Immunol, 115 (1), 136-43
DOI 10.1046/j.1365-2249.1999.00757.x, PubMed 9933433

Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L (1999)
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
Circulation, 100 (6), 614-20
DOI 10.1161/01.cir.100.6.614, PubMed 10441098

Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L (1999)
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Am J Cardiol, 83 (3), 376-82
DOI 10.1016/s0002-9149(98)00872-8, PubMed 10072227

Aukrust P, Aandahl EM, Skålhegg BS, Nordøy I, Hansson V, Taskén K, Frøland SS, Müller F (1999)
Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency
J Immunol, 162 (2), 1178-85
PubMed 9916750

Bjøro K, Haaland T, Skaug K, Frøland SS (1999)
The spectrum of hepatobiliary disease in primary hypogammaglobulinaemia
J Intern Med, 245 (5), 517-24
DOI 10.1046/j.1365-2796.1999.00457.x, PubMed 10363753

Bjøro K, Skaug K, Haaland T, Frøland SS (1999)
Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia
QJM, 92 (8), 433-41
DOI 10.1093/qjmed/92.8.433, PubMed 10627859

Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, Frøland SS, Fowler M (1999)
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
J Am Coll Cardiol, 34 (7), 2061-7
DOI 10.1016/s0735-1097(99)00495-7, PubMed 10588224

Gullestad L, Simonsen S, Ueland T, Holm T, Aass H, Andreassen AK, Madsen S, Geiran O, Frøland SS, Aukrust P (1999)
Possible role of proinflammatory cytokines in heart allograft coronary artery disease
Am J Cardiol, 84 (9), 999-1003
DOI 10.1016/s0002-9149(99)00487-7, PubMed 10569653

Kvale D, Aukrust P, Osnes K, Müller F, Frøland SS (1999)
CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS
AIDS, 13 (2), 195-201
DOI 10.1097/00002030-199902040-00007, PubMed 10202825

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
J Infect Dis, 180 (1), 195-8
DOI 10.1086/314849, PubMed 10353879

Stylianou E, Aukrust P, Kvale D, Müller F, Frøland SS (1999)
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy
Clin Exp Immunol, 116 (1), 115-20
DOI 10.1046/j.1365-2249.1999.00865.x, PubMed 10209514

Aandahl EM, Aukrust P, Müller F, Hansson V, Taskén K, Frøland SS (1999)
Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART
AIDS, 13 (17), F109-14
DOI 10.1097/00002030-199912030-00001, PubMed 10597771

Publications 1998

Andreassen AK, Nordøy I, Simonsen S, Ueland T, Müller F, Frøland SS, Gullestad L, Aukrust P (1998)
Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
Am J Cardiol, 81 (5), 604-8
DOI 10.1016/s0002-9149(97)00972-7, PubMed 9514458

Aukrust P, Müller F, Frøland SS (1998)
Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy
J Infect Dis, 177 (4), 1091-6
DOI 10.1086/517402, PubMed 9534990

Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L (1998)
Elevated circulating levels of C-C chemokines in patients with congestive heart failure
Circulation, 97 (12), 1136-43
DOI 10.1161/01.cir.97.12.1136, PubMed 9537339

Bjøro K, Schrumpf E, Bergan A, Haaland T, Skaug K, Frøland SS (1998)
Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia
Scand J Infect Dis, 30 (5), 520-2
DOI 10.1080/00365549850161575, PubMed 10066058

Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS (1998)
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis
J Clin Endocrinol Metab, 83 (11), 3832-8
DOI 10.1210/jcem.83.11.5270, PubMed 9814454

Haug CJ, Müller F, Aukrust P, Frøland SS (1998)
Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls
Immunol Lett, 63 (2), 107-12
DOI 10.1016/s0165-2478(98)00065-0, PubMed 9761372

Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P (1998)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
FASEB J, 12 (1), 79-89
DOI 10.1096/fasebj.12.1.79, PubMed 9438413

Lien E, Aukrust P, Sundan A, Müller F, Frøland SS, Espevik T (1998)
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events
Blood, 92 (6), 2084-92
DOI 10.1182/blood.V92.6.2084.418k26_2084_2092, PubMed 9731066

Müller F, Aukrust P, Lien E, Haug CJ, Frøland SS (1998)
Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection
J Infect Dis, 177 (3), 586-94
DOI 10.1086/514222, PubMed 9498436

Müller F, Aukrust P, Nordoy I, Froland SS (1998)
Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion
Blood, 92 (10), 3721-9
DOI 10.1182/blood.V92.10.3721.422k11_3721_3729, PubMed 9808566

Nordøy I, Müller F, Aukrust P, Frøland SS (1998)
Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes
Clin Exp Immunol, 114 (2), 258-63
DOI 10.1046/j.1365-2249.1998.00719.x, PubMed 9822285

Aandahl EM, Aukrust P, Skålhegg BS, Müller F, Frøland SS, Hansson V, Taskén K (1998)
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients
FASEB J, 12 (10), 855-62
DOI 10.1096/fasebj.12.10.855, PubMed 9657525

Publications 1997

Aukrust P, Berge RK, Müller F, Ueland PM, Svardal AM, Frøland SS (1997)
Elevated plasma levels of reduced homocysteine in common variable immunodeficiency--a marker of enhanced oxidative stress
Eur J Clin Invest, 27 (9), 723-30
DOI 10.1046/j.1365-2362.1997.18807328.x, PubMed 9352241

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordøy I, Espevik T, Müller F, Frøland SS (1997)
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection
J Infect Dis, 176 (4), 913-23
DOI 10.1086/516510, PubMed 9333149

Aukrust P, Müller F, Nordøy I, Haug CJ, Frøland SS (1997)
Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
Clin Exp Immunol, 107 (1), 50-6
DOI 10.1046/j.1365-2249.1997.d01-904.x, PubMed 9010256

Eskild A, Magnus P, Brekke T, Bruun JN, Heger B, Frøland SS, Moi H, Samdal HH, Løvik M, Bakketeig LS (1997)
The impact of exposure group on the progression rate to acquired immunodeficiency syndrome. A comparison between intravenous drug users, homosexual men and heterosexually infected subjects
Scand J Infect Dis, 29 (2), 103-9
DOI 10.3109/00365549709035868, PubMed 9181643

Hestdal K, Aukrust P, Müller F, Lien E, Bjerkeli V, Espevik T, Frøland SS (1997)
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load
Blood, 90 (7), 2670-9
DOI 10.1182/blood.V90.7.2670.2670_2670_2679, PubMed 9326234

Jonassen TO, Stene-Johansen K, Berg ES, Hungnes O, Lindboe CF, Frøland SS, Grinde B (1997)
Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s
Virology, 231 (1), 43-7
DOI 10.1006/viro.1997.8510, PubMed 9143301

Vorechovský I, Luo L, Hertz JM, Frøland SS, Klemola T, Fiorini M, Quinti I, Paganelli R, Ozsahin H, Hammarström L, Webster AD, Smith CI (1997)
Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia
Hum Mutat, 9 (5), 418-25
DOI 10.1002/(SICI)1098-1004(1997)9:5<418::AID-HUMU7>3.0.CO;2-#, PubMed 9143921

Publications 1996

Aukrust P, Lien E, Kristoffersen AK, Müller F, Haug CJ, Espevik T, Frøland SS (1996)
Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences
Blood, 87 (2), 674-81
DOI 10.1182/blood.V87.2.674.bloodjournal872674, PubMed 8555490

Aukrust P, Svardal AM, Müller F, Lunden B, Nordøy I, Frøland SS (1996)
Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
Blood, 88 (7), 2626-33
DOI 10.1182/blood.V88.7.2626.bloodjournal8872626, PubMed 8839856

Bentdal OH, Frøland SS, Bosnes V, Bergan A, Søreide O, Flatmark A (1996)
Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus
Cancer Lett, 100 (1-2), 133-8
DOI 10.1016/0304-3835(95)04080-3, PubMed 8620432

Haug CJ, Aukrust P, Lien E, Müller F, Espevik T, Frøland SS (1996)
Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D
J Infect Dis, 173 (1), 259-62
DOI 10.1093/infdis/173.1.259, PubMed 8537672

Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
APMIS, 104 (7-8), 539-48
DOI 10.1111/j.1699-0463.1996.tb04909.x, PubMed 8920807

Müller F, Svardal AM, Aukrust P, Berge RK, Ueland PM, Frøland SS (1996)
Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection
Am J Clin Nutr, 63 (2), 242-8
DOI 10.1093/ajcn/63.2.242, PubMed 8561066

Nilssen DE, Müller F, Oktedalen O, Frøland SS, Fausa O, Halstensen TS, Brandtzaeg P (1996)
Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS
J Virol, 70 (6), 3545-50
DOI 10.1128/JVI.70.6.3545-3550.1996, PubMed 8648688

Nordøy I, Aukrust P, Müller F, Frøland SS (1996)
Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections
Clin Immunol Immunopathol, 81 (1), 16-21
DOI 10.1006/clin.1996.0151, PubMed 8808636

Publications 1995

Aukrust P, Liabakk NB, Müller F, Espevik T, Frøland SS (1995)
Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation
Infection, 23 (1), 9-15
DOI 10.1007/BF01710050, PubMed 7744500

Aukrust P, Svardal AM, Müller F, Lunden B, Berge RK, Frøland SS (1995)
Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress
Blood, 86 (4), 1383-91
DOI 10.1182/blood.V86.4.1383.bloodjournal8641383, PubMed 7632946

Aukrust P, Svardal AM, Müller F, Lunden B, Berge RK, Ueland PM, Frøland SS (1995)
Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection
Blood, 86 (1), 258-67
DOI 10.1182/blood.V86.1.258.bloodjournal861258, PubMed 7795231

Bjøro K, Krarup H, Bell H, Christophersen P, Evensen S, Frøland SS, Laursen A, B vd Lippe B, Maeland A, Ranek L (1995)
Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
Scand J Gastroenterol, 30 (11), 1119-24
DOI 10.3109/00365529509101617, PubMed 8578174

Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G (1995)
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
Lancet, 345 (8946), 365-9
DOI 10.1016/s0140-6736(95)90346-1, PubMed 7845120

Gardulf A, Björvell H, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Nyström T, Søeberg B (1995)
Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy
J Adv Nurs, 21 (5), 917-27
DOI 10.1046/j.1365-2648.1995.21050917.x, PubMed 7541407

Karlsen NR, Reinvang I, Frøland SS (1995)
A follow-up study of neuropsychological functioning in AIDS-patients. Prognostic significance and effect of zidovudine therapy
Acta Neurol Scand, 91 (3), 215-21
DOI 10.1111/j.1600-0404.1995.tb00437.x, PubMed 7793239

Müller F, Aukrust P, Nilssen DE, Frøland SS (1995)
Reduced serum level of transforming growth factor-beta in patients with IgA deficiency
Clin Immunol Immunopathol, 76 (2), 203-8
DOI 10.1006/clin.1995.1116, PubMed 7614739

Müller F, Haug CJ, Frøland SS (1995)
[New immunopathogenetic aspects of infectious diseases]
Tidsskr Nor Laegeforen, 115 (26), 3259-62
PubMed 7482454

Publications 1994

Aukrust P, Frøland SS, Liabakk NB, Müller F, Nordøy I, Haug C, Espevik T (1994)
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
Blood, 84 (7), 2136-43
PubMed 7919327

Aukrust P, Liabakk NB, Müller F, Lien E, Espevik T, Frøland SS (1994)
Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters
J Infect Dis, 169 (2), 420-4
DOI 10.1093/infdis/169.2.420, PubMed 7906293

Aukrust P, Müller F, Frøland SS (1994)
Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes
Clin Immunol Immunopathol, 70 (3), 217-24
DOI 10.1006/clin.1994.1032, PubMed 7906214

Aukrust P, Müller F, Frøland SS (1994)
Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency
Clin Exp Immunol, 97 (2), 232-8
DOI 10.1111/j.1365-2249.1994.tb06073.x, PubMed 8050170

Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T (1994)
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
N Engl J Med, 331 (24), 1607-11
DOI 10.1056/NEJM199412153312402, PubMed 7526215

Eskild A, Heger B, Bruun JN, Frøland SS, Iversen B, Løvik M, Samdal HH, Magnus P, Bakketeig LS (1994)
[Risk of AIDS in the Oslo HIV-cohort study. A comparison between homosexual men, intravenous addicts and heterosexual persons]
Tidsskr Nor Laegeforen, 114 (24), 2831-4
PubMed 7998028

Frøland SS (1994)
[Priority decisions in hospital departments]
Tidsskr Nor Laegeforen, 114 (9), 1107-8
PubMed 8009535

Haug C, Müller F, Aukrust P, Frøland SS (1994)
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival
J Infect Dis, 169 (4), 889-93
DOI 10.1093/infdis/169.4.889, PubMed 7907645

Karlsen NR, Frøland SS, Reinvang I (1994)
HIV-related neuropsychological impairment and immunodeficiency. CD8+ lymphocytes and neopterin are related to HIV-encephalopathy
Scand J Psychol, 35 (3), 230-9
DOI 10.1111/j.1467-9450.1994.tb00947.x, PubMed 7939485

Müller F, Frøland SS, Aukrust P, Fagerhol MK (1994)
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events
J Acquir Immune Defic Syndr (1988), 7 (9), 931-9
PubMed 7914232

Publications 1993

Frøland SS (1993)
[HIV, nutrition and immune defence]
Tidsskr Nor Laegeforen, 113 (3), 315-6
PubMed 8441974

Karlsen NR, Reinvang I, Frøland SS (1993)
A follow-up study of neuropsychological function in asymptomatic HIV-infected patients
Acta Neurol Scand, 87 (2), 83-7
DOI 10.1111/j.1600-0404.1993.tb04082.x, PubMed 8442400

Müller F, Frøland SS, Brandtzaeg P, Fagerhol MK (1993)
Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus
Clin Infect Dis, 16 (2), 301-2
DOI 10.1093/clind/16.2.301, PubMed 8443314

Nilssen DE, Aukrust P, Frøland SS, Müller F, Fausa O, Halstensen TS, Brandtzaeg P (1993)
Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency
Clin Exp Immunol, 94 (1), 91-8
DOI 10.1111/j.1365-2249.1993.tb05983.x, PubMed 8403524

Nilssen DE, Halstensen TS, Frøland SS, Fausa O, Brandtzaeg P (1993)
Distribution and phenotypes of duodenal intraepithelial gamma/delta T cells in patients with various types of primary B-cell deficiency
Clin Immunol Immunopathol, 68 (3), 301-10
DOI 10.1006/clin.1993.1131, PubMed 8103721

Nilssen DE, Halstensen TS, Frøland SS, Fausa O, Brandtzaeg P (1993)
Intestinal intraepithelial gamma/delta T cells in B-cell deficiency
Immunodeficiency, 4 (1-4), 71-2
PubMed 8167738

Rollag H, Thorvaldsen J, Kittelsen P, Bjøro K, Frøland S (1993)
[Hepatitis C virus infections among persons attending special clinics dealing with problems related to social conditions]
Tidsskr Nor Laegeforen, 113 (19), 2397-400
PubMed 7690995

Publications 1992

Aukrust P, Farstad IN, Frøland SS, Holter E (1992)
Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication?
Eur Respir J, 5 (3), 362-4
PubMed 1315296

Aukrust P, Frøland SS, Müller F (1992)
Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features
Clin Exp Immunol, 89 (2), 211-6
DOI 10.1111/j.1365-2249.1992.tb06934.x, PubMed 1638765

Karlsen NR, Reinvang I, Frøland SS (1992)
Slowed reaction time in asymptomatic HIV-positive patients
Acta Neurol Scand, 86 (3), 242-6
DOI 10.1111/j.1600-0404.1992.tb05078.x, PubMed 1414240

Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS (1992)
Nonspecific oral immunity in individuals with HIV infection
J Acquir Immune Defic Syndr (1988), 5 (1), 46-51
PubMed 1371157

Nilssen DE, Brandtzaeg P, Frøland SS, Fausa O (1992)
Subclass composition and J-chain expression of the 'compensatory' gastrointestinal IgG cell population in selective IgA deficiency
Clin Exp Immunol, 87 (2), 237-45
DOI 10.1111/j.1365-2249.1992.tb02981.x, PubMed 1735187

NORRBY SR, GOTZSCHE PC, MELANDER H, ANDERSEN P, LAHDEVIRTA J, GUDMUNDSSON S, BRUUN JN, BERGLUND O, SKINHOJ P, GERSTOFT J, THYBO S, GIEMSING P, SOEBERG B, ISAGER H, MOLLER A, KROON S, MAELAND A, DOBLOUG JH, FROLAND S, SCHREINER A, HELLUM KB, LINDBACK S, JACOBSSON B, PEHRSON PO, SKOLDENBERG B et al. (1992)
DOUBLE-BLIND DOSE-RESPONSE STUDY OF ZIDOVUDINE IN AIDS AND ADVANCED HIV-INFECTION
Br. Med. J., 304 (6818), 13-17

Publications 1991

Aukrust P, Frøland SS, Kvale D, Egge K, Farstad IN, Holter E, Moum B (1991)
[Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]
Tidsskr Nor Laegeforen, 111 (28), 3379-84
PubMed 1665253

Bentdal OH, Frøland SS, Djøseland O (1991)
Alterations in serum cortisol, CD4+ CD8+ lymphocyte sub-population ration and T cell mediated suppression of immune responses in the malnutrition of anorexia nervosa
Clin Nutr, 10 (3), 167-72
DOI 10.1016/0261-5614(91)90053-f, PubMed 16839913

Brinchmann JE, Vartdal F, Thorsby E, Bucher A, Frøland SS, Kittelsen P, Kristoffersen J, Baklien K (1991)
[Quantification of T-lymphocyte subpopulations. Immunological marker in human immunodeficiency virus infections]
Tidsskr Nor Laegeforen, 111 (4), 440-3
PubMed 2006482

Frøland SS (1991)
[The HIV-epidemics--many unsolved problems, but also some progress]
Tidsskr Nor Laegeforen, 111 (4), 423-4
PubMed 2006476

Moum B, Aukrust P, Bjørneklett A, Frøland SS, Farstad IN, Holter E (1991)
[Cytomegalovirus disease in the gastrointestinal tract]
Tidsskr Nor Laegeforen, 111 (28), 3388-91
PubMed 1665255

Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P (1991)
Both IgA subclasses are reduced in parotid saliva from patients with AIDS
Clin Exp Immunol, 83 (2), 203-9
DOI 10.1111/j.1365-2249.1991.tb05615.x, PubMed 1899629

Reinvang I, Frøland SS, Karlsen NR, Lundervold AJ (1991)
Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine
AIDS, 5 (2), 228-9
DOI 10.1097/00002030-199102000-00018, PubMed 2031698

Reinvang I, Frøland SS, Skripeland V (1991)
Prevalence of neuropsychological deficit in HIV infection. Incipient signs of AIDS dementia complex in patients with AIDS
Acta Neurol Scand, 83 (5), 289-93
DOI 10.1111/j.1600-0404.1991.tb04703.x, PubMed 2063651

Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991)
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
Scand J Infect Dis, 23 (6), 675-9
DOI 10.3109/00365549109024292, PubMed 1815327

Publications 1990

Dahl-Hansen E, Siebke JC, Frøland SS, Degré M (1990)
Immunogenicity of yeast-derived hepatitis B vaccine from two different producers
Epidemiol Infect, 104 (1), 143-9
DOI 10.1017/s0950268800054625, PubMed 2137785

Frøland SS (1990)
Antimicrobial chemoprophylaxis in immunocompromised patients
Scand J Infect Dis Suppl, 70, 130-40
PubMed 2287895

Haukenes G, Bruun J, Frøland S, Samdal HH (1990)
[Silent HIV infection in HIV seronegative persons]
Tidsskr Nor Laegeforen, 110 (1), 66-7
PubMed 2300943

Müller F, Rollag H, Frøland SS (1990)
Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects
Clin Exp Immunol, 82 (1), 10-5
DOI 10.1111/j.1365-2249.1990.tb05396.x, PubMed 1976461

Müller F, Rollag H, Frøland SS (1990)
Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection
J Biol Regul Homeost Agents, 4 (3), 93-7
PubMed 2135379

Müller F, Rollag H, Gaudernack G, Frøland SS (1990)
Impaired in vitro survival of monocytes from patients with HIV infection
Clin Exp Immunol, 81 (1), 25-30
DOI 10.1111/j.1365-2249.1990.tb05286.x, PubMed 1974179

Rollag H, Evensen SA, Frøland SS, Glomstein A (1990)
Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects
Blut, 60 (2), 93-6
DOI 10.1007/BF01720514, PubMed 2154272

Rollag H, Evesen SA, Fröland SS, Glomstein A (1990)
Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools
Eur J Clin Microbiol Infect Dis, 9 (8), 612-4
DOI 10.1007/BF01967219, PubMed 2170135

Publications 1989

Bentdal OH, Frøland SS, Larsen S (1989)
Cell-mediated immunity in anorexia nervosa augmented lymphocyte transformation response to concanavalin A and lack of increased risk of infection
Clin Nutr, 8 (5), 253-8
DOI 10.1016/0261-5614(89)90035-6, PubMed 16837297

Jacobsen MB, Frøland S, Teigen K (1989)
[Toxic shock syndrome without any relation to the use of tampons or staphylococcal infection]
Tidsskr Nor Laegeforen, 109 (16), 1773-4
PubMed 2749653

Müller F, Frøland SS, Brandtzaeg P (1989)
Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV)
Clin Exp Immunol, 78 (2), 153-8
PubMed 12412741

Müller F, Rollag H, Frøland SS (1989)
Nitroblue tetrazolium reduction in monocytes and monocyte-derived macrophages. Effect of oxidative burst stimulants and interferons
APMIS, 97 (6), 490-6
DOI 10.1111/j.1699-0463.1989.tb00821.x, PubMed 2472158

Nilssen DE, Høverstad T, Frøland SS, Midtvedt T (1989)
Short-chain fatty acids and other intestinal microflora-associated characteristics in faeces of patients with severe B-cell immunodeficiency
Scand J Gastroenterol, 24 (1), 21-7
DOI 10.3109/00365528909092234, PubMed 2784588

Publications 1988

Brandtzaeg P, Oyen O, Jahnsen T, Fausa O, Frøland S, Sauar J (1988)
[Crohn disease or non-Hodgkin's malignant T cell lymphoma? A diagnostic problem evaluated by gene technology DNA analysis]
Tidsskr Nor Laegeforen, 108 (12), 906-11
PubMed 3289137

Chiodi F, Norkrans G, Hagberg L, Sönnerborg A, Gaines H, Frøland S, Fenyö EM, Norrby E, Vandvik B (1988)
Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation
J Neurol Sci, 87 (1), 37-48
DOI 10.1016/0022-510x(88)90052-4, PubMed 3142965

Frøland SS, Jenum P, Lindboe CF, Wefring KW, Linnestad PJ, Böhmer T (1988)
HIV-1 infection in Norwegian family before 1970
Lancet, 1 (8598), 1344-5
DOI 10.1016/s0140-6736(88)92164-2, PubMed 2897596

Høeg V, Schrumpf E, Blomhoff JP, Frøland S, Rollag H, Stokke O, Aasen AO (1988)
[Etiology of chronic pancreatitis]
Tidsskr Nor Laegeforen, 108 (31), 2834-7
PubMed 3201447

Lindboe CF, Frøland SS (1988)
Unusual nuclear inclusions in CNS macrophages of a man with encephalomyelitis and acquired immunodeficiency
Ultrastruct Pathol, 12 (1), 145-50
DOI 10.3109/01913128809048483, PubMed 3354072

Mellbye OJ, Frøland SS, Lilleaasen P, Svennevig JL, Mollnes TE (1988)
Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70
Eur Surg Res, 20 (2), 101-9
DOI 10.1159/000128748, PubMed 2455645

Nilssen DE, Frøland SS, Tausjø JE (1988)
[Idiopathic midline destructive disease]
Tidsskr Nor Laegeforen, 108 (28), 2385-7
PubMed 3206448

Rognum TO, Thorbjørnsen SO, Frøland SS (1988)
AIDS: frykt og fakta : utfordring til handling og omsorg
Ansgar, [Oslo], 95 s.
BIBSYS 894008668, ISBN 82-503-0849-2

Publications 1987

Albrechtsen DH, Evensen SA, Frøland S, Stavem P, Lie SO, Steinbakk M, Rollag H, Solheim B, Thorsby E, Jacobsen AB (1987)
[Allogeneic bone marrow transplantation in Norway]
Tidsskr Nor Laegeforen, 107 (26), 2222-4
PubMed 3313797

Evensen SA, Ulstrup J, Skaug K, Frøland SS, Glomstein A, Rollag H (1987)
HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors
Eur J Haematol, 39 (1), 44-8
DOI 10.1111/j.1600-0609.1987.tb00162.x, PubMed 3115823

Frøland S (1987)
[AIDS is no prairie fire. Interview by Gunnar Bolstad]
Sykepleien, 74 (15), 13-5, 40-1
PubMed 3686365

HASKJOLD E, FROLAND S, EGGE K (1987)
OCULAR POLYARTERITIS NODOSA - REPORT OF A CASE
Acta Ophthalmol., 65 (6), 749-751

Håskjold E, Frøland S, Egge K (1987)
Ocular polyarteritis nodosa. Report of a case
Acta Ophthalmol (Copenh), 65 (6), 749-51
DOI 10.1111/j.1755-3768.1987.tb07076.x, PubMed 2893509

Rollag H, Evensen SA, Frøland SS, Glomstein A (1987)
The significance of HIV antigen and HIV antibodies specific against envelope and core proteins in serum of HIV-infected hemophiliacs
Eur J Haematol, 39 (4), 353-5
DOI 10.1111/j.1600-0609.1987.tb00782.x, PubMed 3480236

Publications 1986

Bentdal OH, Flatmark A, Frøland SS (1986)
[Protein-calorie malnutrition. Diagnosis and preoperative parenteral nutrition of patients at risk]
Tidsskr Nor Laegeforen, 106 (11), 908-11
PubMed 3088760

Evensen SA, Frøland SS, Glomstein A (1986)
[Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives]
Tidsskr Nor Laegeforen, 106 (1), 19-21
PubMed 3006278

Frøland S (1986)
AIDS: en utfordring til oss alle
Gyldendal, Oslo, 246 s.
BIBSYS 864178611, ISBN 82-05-16981-0

Gulsvik A, Kjelsberg F, Bergmann A, Frøland SS, Rootwelt K, Vale JR (1986)
High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study
Respiration, 50 (4), 252-7
DOI 10.1159/000194935, PubMed 3823635

Lindboe CF, Frøland SS, Wefring KW, Linnestad PJ, Bøhmer T, Foerster A, Løken AC (1986)
Autopsy findings in three family members with a presumably acquired immunodeficiency syndrome of unknown etiology
Acta Pathol Microbiol Immunol Scand A, 94 (2), 117-23
DOI 10.1111/j.1699-0463.1986.tb02973.x, PubMed 3487198

Schrumpf E, Frøland S (1986)
[Viral hepatitis. New clinical aspects]
Tidsskr Nor Laegeforen, 106 (23), 1804-6
PubMed 3764854

Ulstrup J, Skaug K, Bruun JN, Petersen G, Frøland S, Levy JA (1986)
[Immunofluorescence test in the diagnosis of AIDS-associated virus infection in Norway]
Tidsskr Nor Laegeforen, 106 (5), 387-9
PubMed 3515622

von der Lippe E, Frøland S, Rollag H, Degre M (1986)
Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
DOI 10.1111/j.1699-0463.1986.tb03064.x, PubMed 3098042

Publications 1985

Frøland SS, Oppedal B, Digranes S, Egge K, Skar AG, Hasvoll A, Onsrud M, Steinbakk M (1985)
Acquired immunodeficiency syndrome (AIDS). Clinical, immunological, pathological, and microbiological studies of the first case diagnosed in Norway
Scand J Gastroenterol Suppl, 107, 82-93
DOI 10.3109/00365528509099757, PubMed 3856941

Mollnes TE, Frøland SS, Harboe M (1985)
Increased plasma levels of the terminal complement complex in patients with evidence of complement activation
Complement, 2 (2-3), 175-84
DOI 10.1159/000467858, PubMed 3878765

Mollnes TE, Lea T, Frøland SS, Harboe M (1985)
Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
Scand J Immunol, 22 (2), 197-202
DOI 10.1111/j.1365-3083.1985.tb01871.x, PubMed 2412280

Publications 1984

Degré M, Siebke JC, Frøland SS (1984)
[Prevention of hepatitis B by vaccination]
Tidsskr Nor Laegeforen, 104 (27), 1906-7
PubMed 6515608

Evensen SA, Frøland SS, Stavem P, Albrechtsen D, Flatmark A (1984)
[Bone marrow transplantation. Indications in adult patients with leukemia or aplastic anemia]
Tidsskr Nor Laegeforen, 104 (23), 1542-4
PubMed 6385336

Frøland SS (1984)
Interaction of microbial agents with the immune system during infectious disease
Acta Otolaryngol Suppl, 407, 14-22
DOI 10.3109/00016488409124958, PubMed 6238501

Frøland SS (1984)
Bacterial infections in the compromised host
Scand J Infect Dis Suppl, 43, 7-16
PubMed 6336011

Frøland SS (1984)
Legionella pneumonia--a neglected diagnosis?
Acta Otolaryngol Suppl, 407, 55-8
DOI 10.3109/00016488409124966, PubMed 6594028

Frøland SS (1984)
Legionella pneumoni: en diagnose som stilles for sjelden
Abbott Norge, Hvalstad, 11 s.
BIBSYS 080259227

Publications 1983

Frøland SS (1983)
Antibiotic-associated colitis
Scand J Gastroenterol Suppl, 85, 74-82
PubMed 6353558

Frøland SS (1983)
[The patient with impaired defense against infections. Types of defect and spectrum of infectious diseases]
Tidsskr Nor Laegeforen, 103 (3), 213-9
PubMed 6687768

Frøland SS (1983)
[Parasite versus immune system - a fight with uncertain outcome]
Tidsskr Nor Laegeforen, 103 (3), 179-82
PubMed 6845310

Frøland SS (1983)
[Immunological disease mechanisms in acute and chronic infections]
Tidsskr Nor Laegeforen, 103 (3), 184-6
PubMed 6845312

Frøland SS (1983)
[Microembolization with granulocyte aggregates caused by complement activation. An important pathogenetic mechanism in bacterial septicemia and shock?]
Tidsskr Nor Laegeforen, 103 (3), 192-4
PubMed 6845316

Frøland SS (1983)
[Vaccination against hepatitis B virus - soon a reality also in Norway]
Tidsskr Nor Laegeforen, 103 (3), 233-6
PubMed 6845331

Frøland SS, Stavem P (1983)
[Immunosuppressive therapy in hematological diseases. Principles and mechanism of action]
Tidsskr Nor Laegeforen, 103 (17-18), 1391-5
PubMed 6623445

Malm OJ, Frøland SS (1983)
Klinisk ernæring: grunnlaget for parenteral og enteral ernæring i klinisk medisin : symposium arrangert i Oslo 19.mars 1982
Oslo KabiVitrum, 119 s.
BIBSYS 021676534

Publications 1982

Evensen SA, Gjone E, Frøland SS, Flatmark A, Aakhus T (1982)
[Medical treatment of fulminating attacks of ulcerative colitis]
Tidsskr Nor Laegeforen, 102 (23), 1158-9
PubMed 7167889

Ly B, Michaelsen TE, Dahl O, Frøland SS (1982)
Characterization of an antibody to factor VIII in a patient with acquired hemophilia with circulating immune complexes
Scand J Haematol, 28 (2), 132-40
DOI 10.1111/j.1600-0609.1982.tb00505.x, PubMed 6806894

Refvem OK, Gulsvik A, Melby K, Frøland SS (1982)
[Job's syndrome]
Tidsskr Nor Laegeforen, 102 (1), 14-5
PubMed 7089923

Publications 1981

Frøland SS (1981)
Infections with Pseudomonas aeruginosa in the compromised host
Scand J Infect Dis Suppl, 29, 72-80
PubMed 6797060

Thorsteinsson L, Abrahamsen TG, Frøland SS (1981)
Plaque-forming, antibody-dependent, cytotoxic cells with monocytic properties are present in rheumatoid synovial tissue
Scand J Rheumatol, 10 (2), 138-44
DOI 10.3109/03009748109095286, PubMed 7017915

Thorsteinsson L, Abrahamsen TG, Frøland SS, Kåss OE (1981)
Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups
Scand J Rheumatol, 10 (1), 49-54
PubMed 6971489

Thorsteinsson L, Abrahamsen TG, Frøland SS, Kåss OE (1981)
Identification and functional characterization of monocytes in rheumatoid synovial fluid
Int Arch Allergy Appl Immunol, 64 (1), 60-66
DOI 10.1159/000232674, PubMed 7005120

Publications 1980

Thorsteinsson L, Michaelsen TE, Frøland SS (1980)
Specificity of receptors for IgG on human cytotoxic plaque-forming mononuclear leukocytes. Induction and inhibition of plaque-forming activity
Int Arch Allergy Appl Immunol, 62 (1), 111-7
DOI 10.1159/000232501, PubMed 6989762

Publications 1979

Abrahamsen TG, Frøland SS, Kåss E, Natvig JB, Pahle J (1979)
Lymphocytes from synovial tissue of a boy with X-linked hypogammaglobulinemia and chronic polyarthritis
Arthritis Rheum, 22 (1), 71-6
DOI 10.1002/art.1780220111, PubMed 365188

Arva P, Frøland SS, Iveland H (1979)
[Hemolytic anemia caused by Mycoplasma pneumoniae infection]
Tidsskr Nor Laegeforen, 99 (13), 633-4
PubMed 451963

Thorsteinsson L, Braathen LR, Frøland SS (1979)
Studies on Fc-receptor-bearing mononuclear leukocytes from peripheral blood of patients with dermatitis herpetiformis
Acta Derm Venereol, 59 (3), 201-4
PubMed 87075

Publications 1978

Abrahamsen TG, Frøland SS, Natvig JB (1978)
In vitro mitogen stimulation of synovial fluid lymphocytes from rheumatoid arthritis and juvenile rheumatoid arthritis patients: dissociation between the response to antigens and polyclonal mitogens
Scand J Immunol, 7 (1), 81-90
DOI 10.1111/j.1365-3083.1978.tb00429.x, PubMed 345418

Bremer K, Engeset A, Fröland SS (1978)
Circulation and emigration kinetics of blood lymphocytes in lymphoma patients
Lymphology, 11 (4), 231-7
PubMed 310921

Forre O, Johnson PM, Froland SS, Natvig JB (1978)
Variable heavy chain (VH) subgroups of human autoantibody molecules. Comparison with Ig classes and light chain types
Clin Immunol Immunopathol, 9 (1), 120-8
DOI 10.1016/0090-1229(78)90128-9, PubMed 411621

Høyeraal HM, Frøland SS, Salvesen CF, Munthe E, Natvig JB, Kåss E, Blichfeldt P, Hegna TM, Revlem E, Sandstad B, Hjort NL (1978)
No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial
Ann Rheum Dis, 37 (2), 175-9
DOI 10.1136/ard.37.2.175, PubMed 348131

Lie SO, Frøland S, Brandtzaeg P, Vandvik B, Steen-Johnsen J (1978)
Transient B cell immaturity with intractable diarrhoea: a possible new immunodeficiency syndrome
J Inherit Metab Dis, 1 (4), 137-43
DOI 10.1007/BF01805582, PubMed 117248

Mellbye OJ, Høyeraal HM, Frøland SS (1978)
C-reactive protein and delayed hypersensitivity in juvenile rheumatoid arthritis
Scand J Rheumatol, 7 (2), 90-2
DOI 10.3109/03009747809098842, PubMed 705274

Nordal HJ, Froland SS (1978)
Lymphocyte populations and cellular immune reactions in vitro in patients with multiple sclerosis
Clin Immunol Immunopathol, 9 (1), 87-96
DOI 10.1016/0090-1229(78)90125-3, PubMed 618413

Winsnes R, Frøland SS, Degré MI (1978)
Effect of transfer factor and zoster immunoglobulin in patients with varicella-zoster infection and malignancy
Scand J Infect Dis, 10 (1), 21-7
DOI 10.3109/inf.1978.10.issue-1.05, PubMed 580314

Publications 1977

Abrahamsen TG, Frøland SS, Natvig JB, Pahle J (1977)
Antibody-dependent cytotoxicity mediated by cells eluted from synovial tissues of patients with rheumatoid arthritis and juvenile rheumatoid arthritis
Scand J Immunol, 6 (12), 1251-61
DOI 10.1111/j.1365-3083.1977.tb00364.x, PubMed 605363

Baklien K, Fausa O, Brandtzaeg P, Fröland SS, Gjone E (1977)
Malabsorption, villous atrophy, and excessive serum IgA in a patient with unusual intestinal immunocyte infiltration
Scand J Gastroenterol, 12 (4), 421-32
DOI 10.3109/00365527709181683, PubMed 329404

Forre O, Froland SS, Natvig JB, Michaelsen TE, Johnson PM, Ly B, Laake K (1977)
A study of the variable heavy chain (VH) region of membrane-bound Ig on human chronic leukemic lymphocytes
J Immunol, 118 (5), 1513-6
PubMed 404355

Thorsteinsson L, Frøland SS, Natvig JB (1977)
Studies of antibody-dependent cytotoxicity in a plaque assay: evidence of human monocyte-like effector cells
Scand J Immunol, 6 (12), 1305-15
DOI 10.1111/j.1365-3083.1977.tb00370.x, PubMed 343229

Publications 1976

Abrahamsen TG, Fróland SS, Natvig JB, Pahle J (1976)
Antigen and unspecific mitogen stimulation of lymphocytes eluted from rheumatoid inflammatory tissue
Scand J Immunol, 5 (9), 1057-63
DOI 10.1111/j.1365-3083.1976.tb03057.x, PubMed 1006168

Berdal P, Brandtzaeg P, Froland SS, Henriksen SD, Skrede S (1976)
Immunodeficiency syndromes with otorhinolaryngological manifestations
Acta Otolaryngol, 82 (3-4), 185-92
DOI 10.3109/00016487609120879, PubMed 1086576

Brandtzæg P, Berdal P, Frøland SS, Henriksen SD, Skrede S (1976)
Immunodeficiency syndromes with oto-rhino-laryngological manifestations
In Forhandlinger (Norsk forening for allergologi og immunopatologi), Fisons, [Oslo], 4-1976, 5[7]s.
BIBSYS 080988024

Forre O, Natvig JB, Froland SS, Johnson PM (1976)
Distribution of heavy-chain variable-region (Vh) subgroups on human lymphocytes
Scand J Immunol, 5 (10), 1221-6
DOI 10.1111/j.1365-3083.1976.tb00266.x, PubMed 827808

Froland SS, Wisloff F, Stavem P (1976)
Abnormal lymphocyte populations in pure red cell aplasia
Scand J Haematol, 17 (4), 241-50
DOI 10.1111/j.1600-0609.1976.tb01181.x, PubMed 1087044

Haneberg B, FROLAND SS, Finne PH, Bakke T, Thunold S, Moe PJ, Tonder O, Solberg CO, Solheim BG, Dalen A (1976)
Fetal thymus transplantations in severe combined immunodeficiency
Scand J Immunol, 5 (8), 917-24
DOI 10.1111/j.1365-3083.1976.tb03042.x, PubMed 11548

Natvig JB, Frøland SS (1976)
Detection of a third lymphocyte-like cell type by rosette formation with erythrocytes sensitized by various anti-Rh antibodies
Scand J Immunol, Suppl 5, 83-9
DOI 10.1111/j.1365-3083.1976.tb03859.x, PubMed 829892

Nordal HJ, Froland SS, Vandvik B, Norrby E (1976)
Measles virus-induced migration inhibition in vitro of leukocytes from patients with multiple sclerosis
Scand J Immunol, 5 (5), 587-91
DOI 10.1111/j.1365-3083.1976.tb00314.x, PubMed 959780

Nordal HJ, Froland SS, Vandvik B, Norrby E (1976)
Measles virus-induced migration inhibition of human leukocytes in vitro: an expression of cell-mediated immunity?
Scand J Immunol, 5 (8), 969-77
DOI 10.1111/j.1365-3083.1976.tb03049.x, PubMed 996451

Salsano F, Froland SS, Natvig JB, Mandelli F (1976)
Chronic lymphocytic leukemia: studies on the effect of drug treatment on different lymphocytic subpopulations
Scand J Immunol, 5 (10), 1185-90
DOI 10.1111/j.1365-3083.1976.tb00261.x, PubMed 1087747

Stavem P, Froland SS, Haugen HF, Lislerud A (1976)
Nonsecretory myelomatosis without intracellular immunoglobulin. Immunofluorescent and ultramicroscopic studies
Scand J Haematol, 17 (2), 89-95
DOI 10.1111/j.1600-0609.1976.tb01159.x, PubMed 788138

Publications 1975

Abrahamsen TG, Froland SS, Natvig JB, Pahle J (1975)
Elution and characterization of lymphocytes from rheumatoid inflammatory tissue
Scand J Immunol, 4 (8), 823-30
DOI 10.1111/j.1365-3083.1975.tb03723.x, PubMed 1082634

Froland SS, Natvig JB, Wisloff F (1975)
Lymphocyte subpopulations in rheumatoid arthritis
Rheumatology, 6, 231-41
PubMed 1081728

Froland SS, Wisloff F (1975)
[Identification and characterization of a 3rd population of human lymphocytes with receptors for IgG (Fc-receptors)]
Medicina (B Aires), 35 (4), 355-68
PubMed 1196111

Heier HE, Christensen I, Froland SS, Engeset A (1975)
Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations
Lymphology, 8 (3), 69-74
PubMed 811930

Hoyeraal HM, Froland SS, Wisloff F (1975)
Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis
Scand J Immunol, 4 (8), 801-10
DOI 10.1111/j.1365-3083.1975.tb02689.x, PubMed 1082632

Munthe E, Hoyeraal HM, Froland SS, Mellbye OJ, Kåss E, Natvig JB (1975)
Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients
Rheumatology, 6, 43-51
PubMed 1081730

Natvig JB, Abrahamsen T, Anders R, Froland SS, Husby G, Hoyeraal HM, Kåss E, Mellbye OJ, Munthe E, Pahle J, Wisloff F (1975)
Lymphocyte subpopulations and immune reactions in rheumatoid inflammatory tissues
Scand J Rheumatol Suppl, 12, 77-88
PubMed 1084571

Natvig JB, Froland SS, Wisloff F, Munthe E (1975)
Different lymphocyte populations in rheumatoid arthritis and their relationship to anti-Ig activities
Ann Clin Res, 7 (3), 146-53
PubMed 1081361

Nordal HJ, Froland SS, Vandvik B, Norrby E (1975)
Letter: Measles-virus-induced migration inhibition of human leucocytes: an immunologically unspecific phenomenon?
Lancet, 2 (7947), 1266-7
DOI 10.1016/s0140-6736(75)92119-4, PubMed 53765

Vesterhus P, Eide J, Froland SS, Haneberg B, Jacobsen KB (1975)
Case report: maldescent of the thymus in a hypoparathyroid infant with Pharyngeal Pouch Syndrome
Acta Paediatr Scand, 64 (3), 555-8
DOI 10.1111/j.1651-2227.1975.tb03880.x, PubMed 1155074

Wisløff F, Frøland SS, Natvig JB (1975)
Deficient lymphoid cell-mediated, PHA-induced cytotoxicity in rheumatoid arthritis patients
Scand J Immunol, 4 (3), 303-7
DOI 10.1111/j.1365-3083.1975.tb02630.x, PubMed 1080292

Publications 1974

Engeset A, Froland SS, Bremer K (1974)
Studies of human peripheral lymph. II. Low lymphocyte count and few B-lymphocytes in peripheral lymph of patients with chronic lymphocytic leukaemia
Scand J Haematol, 13 (2), 93-100
DOI 10.1111/j.1600-0609.1974.tb00241.x, PubMed 4547504

Froland SS (1974)
[Immunological classification of lymphoproliferative conditions]
Tidsskr Nor Laegeforen, 94 (32), 2220-3
PubMed 4531116

Froland SS, Michaelsen TE, Wisloff F, Natvig JB (1974)
Specificity of receptors for IgG on human lymphocyte-like cells
Scand J Immunol, 3 (4), 509-17
DOI 10.1111/j.1365-3083.1974.tb01284.x, PubMed 4137203

Froland SS, Natvig JB, Hoyeraal HM, Kåss E (1974)
The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor
Scand J Immunol, 3 (2), 223-8
DOI 10.1111/j.1365-3083.1974.tb01252.x, PubMed 4207152

Froland SS, Natvig JB, Michaelsen TE (1974)
Binding of aggregated IgG BY HUMAN B lymphocytes independent of Fc receptors
Scand J Immunol, 3 (3), 375-80
DOI 10.1111/j.1365-3083.1974.tb01268.x, PubMed 4546736

Froland SS, Wisloff F, Michaelsen TE (1974)
Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes
Int Arch Allergy Appl Immunol, 47 (1), 124-38
DOI 10.1159/000231207, PubMed 4546531

Gulsvik A, Schaanning CG, Brandtzaeg P, Froland SS, Hellum KB, Hoyeraal HM (1974)
[Immunodeficiency--a cause of recurrent airway infections in adults]
Tidsskr Nor Laegeforen, 94 (31), 2152-5
PubMed 4139780

Kåss E, Froland SS, Natvig JB, Blichfeldt P, Hoyeraal HM (1974)
Letter: Transfer factor in juvenile rheumatoid arthritis
Lancet, 1 (7858), 627-8
DOI 10.1016/s0140-6736(74)92687-7, PubMed 4132291

Kåss E, Froland SS, Natvig JB, Blichfeldt P, Hoyeraal HM, Munthe E (1974)
A new principle of immunotherapy in rheumatoid arthritis: treatment with transfer factor
Scand J Rheumatol, 3 (3), 113-7
DOI 10.3109/03009747409097134, PubMed 4428189

Natvig JB, Froland SS (1974)
Surface-bound immunoglobulin on B-lymphocytes, evidence for allelic exclusion
Ann Immunol (Paris), 125C (1-2), 281-6
PubMed 4142558

Salsano F, Froland SS, Natvig JB, Michaelsen TE (1974)
Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells
Scand J Immunol, 3 (6), 841-6
DOI 10.1111/j.1365-3083.1974.tb01321.x, PubMed 4142108

Stavem P, Hovig T, Froland S, Skrede S (1974)
Immunoglobulin-containing intranuclear inclusions in plasma cells in a case of IgG myeloma
Scand J Haematol, 13 (4), 266-75
DOI 10.1111/j.1600-0609.1974.tb00269.x, PubMed 4141124

Wisloff F, Froland SS, Engeset A (1974)
Selective defects of in vitro parameters of lymphoid cell function in patients with irradiated testicular tumour and in patients with lymphoproliferative disorders
Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (2), 263-9
DOI 10.1111/j.1699-0463.1974.tb02321.x, PubMed 4546906

Wisloff F, Froland SS, Michaelsen TE (1974)
Characterization of subpopulations of human lymphoid cells participating in phytohemagglutinin and concanavalin A-induced cytotoxicity
Int Arch Allergy Appl Immunol, 47 (4), 488-97
DOI 10.1159/000231243, PubMed 4547156

Wisloff F, Froland SS, Michaelsen TE (1974)
Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes
Int Arch Allergy Appl Immunol, 47 (1), 139-54
DOI 10.1159/000231208, PubMed 4603056

Wisloff F, Michaelsen TE, Froland SS (1974)
Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments
Scand J Immunol, 3 (1), 29-38
DOI 10.1111/j.1365-3083.1974.tb01230.x, PubMed 4857243

Publications 1973

Engeset A, Abrahamsen AF, Bremer K, Brennhovd IO, Christensen I, Fröland SS, Hager B, Höeg K, Höst H, Nesheim A (1973)
Peripheral and central lymph in Hodgkin's disease: preliminary report
Natl Cancer Inst Monogr, 36, 247-52
PubMed 4542773

Engeset A, Fröland SS, Bremer K, Host H (1973)
Blood lymphocytes in Hodgkin's disease. Increase of B-lymphocytes following extended field irradiation
Scand J Haematol, 11 (3), 195-200
DOI 10.1111/j.1600-0609.1973.tb00116.x, PubMed 4543611

Froland SS, Gaarder PI (1973)
The effect of IgG in vitro on leukocytes from patients with rheumatoid arthritis
Scand J Immunol, 2 (4), 385-93
DOI 10.1111/j.1365-3083.1973.tb02047.x, PubMed 4797729

Froland SS, Natvig JB (1973)
Identification of three different human lymphocyte populations by surface markers
Transplant Rev, 16, 114-62
DOI 10.1111/j.1600-065x.1973.tb00119.x, PubMed 4590767

Froland SS, Natvig JB, Husby G (1973)
Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis
Scand J Immunol, 2 (1), 67-73
DOI 10.1111/j.1365-3083.1973.tb02017.x, PubMed 4580484

Frøland SS (1973)
Human B and T lymphocytes: detection and characterization of membrane-bound immunoglobulin and other lymphocyte markers
Universitetsforl., Oslo, 1 b. (flere pag.)
BIBSYS 962168890

Myrvang B, Godal T, Ridley DS, Fröland SS, Song YK (1973)
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy
Clin Exp Immunol, 14 (4), 541-53
PubMed 4583777

Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degré M (1973)
Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor
Scand J Immunol, 2 (4), 367-74
DOI 10.1111/j.1365-3083.1973.tb02045.x, PubMed 4797728

Wisloff F, Froland SS (1973)
Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin
Scand J Immunol, 2 (2), 151-7
DOI 10.1111/j.1365-3083.1973.tb02026.x, PubMed 4542262

Wislöff F, Fröland SS (1973)
Studies on the cytotoxic activity of human lymphoid cells activated by concanavalin A
Int Arch Allergy Appl Immunol, 45 (3), 456-66
DOI 10.1159/000231063, PubMed 4542732

Publications 1972

Catovsky D, Tripp E, Hoffbrand AV, König E, Cohnen G, Brittinger G, Douglas SD, Fröland SS, Stavem P (1972)
Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemia
Lancet, 1 (7754), 794-6
PubMed 4111271

Froland S (1972)
[Lymphokines]
Tidsskr Nor Laegeforen, 92 (11), 775-7
PubMed 5028900

Froland SS, Natvig JB (1972)
Surface-bound immunoglobulin on lymphocytes from normal and immunodeficient humans
Scand J Immunol, 1 (1), 1-12
DOI 10.1111/j.1365-3083.1972.tb03730.x, PubMed 4561501

Froland SS, Natvig JB, Stavem P (1972)
Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig
Scand J Immunol, 1 (4), 351-60
DOI 10.1111/j.1365-3083.1972.tb03301.x, PubMed 4590280

Fröland SS (1972)
Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes
Scand J Immunol, 1 (3), 269-80
DOI 10.1111/j.1365-3083.1972.tb01818.x, PubMed 4541574

Fröland SS, Natvig JB (1972)
Class, subclass, and allelic exclusion of membrane-bound Ig of human B lymphocytes
J Exp Med, 136 (2), 409-14
DOI 10.1084/jem.136.2.409, PubMed 4557774

Fröland SS, Natvig JB (1972)
Lymphocytes with membrane-bound immunoglobulin (B-lymphocytes) in new-born babies
Clin Exp Immunol, 11 (4), 495-505
PubMed 4563709

Godal T, Myrvang B, Froland SS, Shao J, Melaku G (1972)
Evidence that the mechanism of immunological tolerance ("central failure") is operative in the lack of host resistance in lepromatous leprosy
Scand J Immunol, 1 (4), 311-21
DOI 10.1111/j.1365-3083.1972.tb03296.x, PubMed 4590279

Publications 1971

Froland SS, Natvig JB (1971)
[2 populations of lymphocytes with different immunological function]
Tidsskr Nor Laegeforen, 91 (23), 1630-6
PubMed 5110436

Froland SS, Natvig JB (1971)
[Cellular immunology]
Tidsskr Nor Laegeforen, 91 (23), 1695-6
PubMed 5110443

Fröland S, Natvig JB, Berdal P (1971)
Surface-bound immunoglobulin as a marker of B lymphocytes in man
Nat New Biol, 234 (51), 251-2
DOI 10.1038/newbio234251a0, PubMed 4942988

Fröland SS, Gaardner PI (1971)
Leucocyte-migration inhibition induced by IgG in rheumatoid arthritis
Lancet, 1 (7708), 1071-2
DOI 10.1016/s0140-6736(71)91634-5, PubMed 4102997

Fröland SS, Natvig JB (1971)
Effect of polyspecific rabbit anti-immunoglobulin antisera on the response of human lymphocytes in mixed lymphocyte culture
Int Arch Allergy Appl Immunol, 41 (2), 248-61
DOI 10.1159/000230523, PubMed 5315631

Lie SO, Froland SS (1971)
[Primary immunological deficiency diseases. Classification, immunological diagnosis and treatment]
Tidsskr Nor Laegeforen, 91 (23), 1647-54
PubMed 4938860

Publications 1970

Fröland SS, Natvig JB (1970)
Effect of polyspecific rabbit anti-immunoglobulin antisera on human lymphocytes in vitro
Int Arch Allergy Appl Immunol, 39 (2-3), 121-32
DOI 10.1159/000230341, PubMed 4990555